Celldom
Founded 2016 · 8 employees on LinkedIn · 2 known investors
Find your way into Celldom
CellDom develops CloneXplorer, a live single-cell assay platform combining functional imaging, molecular readouts, and integrated cell retrieval for high-resolution cell analysis. The platform enables CAR T-cell potency testing, antibody/TCR discovery, cell line development, and precision medicine applications for research and therapeutic development teams.
Investors · 2
Frequently asked questions
- What does Celldom do?
- CellDom develops CloneXplorer, a live single-cell assay platform combining functional imaging, molecular readouts, and integrated cell retrieval for high-resolution cell analysis. The platform enables CAR T-cell potency testing, antibody/TCR discovery, cell line development, and precision medicine applications for research and therapeutic development teams.
- Who are Celldom's investors?
- Celldom's investors include First In Ventures, TSVC.